Development of high performance liquid chromatography method for buspirone in rabbit serum: Application to pharmacokinetic study

Analytica Chimica Acta

Volumn 647, Issue 2, 2009, Pages 226-230

  Gannu, Ramesh ^a   Yamsani, Shravan Kumar ^a   Palem, Chinna Reddy ^a   Yamsani, Vamshi Vishnu ^a   Kotagiri, Harshini ^a   Yamsani, Madhusudan Rao ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

Buspirone; Pharmacokinetics; Rabbit serum; Reversed phase high performance liquid chromatography

Indexed keywords

ASSAY METHODS; BUSPIRONE; COEFFICIENT OF VARIATION; DILTIAZEM HYDROCHLORIDE; ERROR VALUES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHODS; INTERNAL STANDARDS; ISOCRATIC MOBILE PHASE; LINEARITY RANGE; PHARMACOKINETIC STUDIES; RABBIT SERUM; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TRANSDERMAL THERAPEUTIC SYSTEMS; UV DETECTOR;

BODY FLUIDS; CHROMATOGRAPHY; DICHLOROMETHANE; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; PHARMACOKINETICS;

CHROMATOGRAPHIC ANALYSIS;

ANSIAL; ANXIOLAN; BUSANSIL; BUSPIROL; BUSPIRONE; DILTIAZEM; HYDROXYZINE; NAROL; NEUROSINE; PASRIN 10; PAXON; RELAX; SORBON; TENSISPES; UNCLASSIFIED DRUG; XIETY;

ACCURACY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG STRUCTURE; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-ANXIETY AGENTS; BUSPIRONE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; RABBITS; SENSITIVITY AND SPECIFICITY;

ORYCTOLAGUS CUNICULUS;

EID: 67649665613     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2009.06.005     Document Type: Article

References (16)

1. Dommisse C.S., and De Vane C.L. Intell. Clin. Pharm. 19 (1985) 624
2. Clarke's analysis of drugs and poisons (2007): www.medicinescomplete.com.
3. Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD, 2001.
4. Roman M., Kronstrand R., Lindstedt D., and Josefsson M. J. Anal. Toxicol. 32 2 (2008) 147
5. Chew W.M., Xu M.J., Cordova C.A., and Chow H.H. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 844 2 (2006) 235
6. Péhourcq F. Biomed. Chromatogr. 18 9 (2004) 637
7. Foroutan S.M., Zarghi A., Shafaati A.R., and Khoddam A. Farmaco 59 9 (2004) 739
8. Betto P., Menequz A., Ricciarrello G., and Pichini S. J. Chromatogr. 575 (1992) 117
9. Ary K., Róna K., Ondi S., and Gachályi B. J. Chromatogr. A. 797 1-2 (1998) 221
10. Kristjánsson F. J. Chromatogr. 566 1 (1991) 250
11. Stanley S.M. J. Mass. Spectrom. 35 3 (2000) 402
12. Kerns E.H., Bullen W.W., and Gamman R.E. J. Chromatogr. 377 (1986) 195
13. Gammans R.E., Mayol R.F., Mackenthun A.V., and Sokya L.F. Biopharm. Drug. Dispos. 6 (1985) 139
14. Bennett P.N., and Brown M.J. Psychotrophic Drugs in: Clinical Pharmacology. 9th ed. (2005), Elsevier, Churchill Livingstone p367-411
15. Shah V.P., Midha K.K., Findlay J.W., Hill H.M., Hulse J.D., Mc Gilveray I.J., Mc Kay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Pharm. Res. 17 (2000) 1551
16. Reviewer Guidance Validation of Chromatographic Methods, Center for Drug Evaluation and Research, Rockville, MD, 1994.